Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care

Inclusion Criteria: * Male or female patients presenting with chronic DFU * The chronic DFU has a surface area that has reduced \<25% in the previous 4 weeks1 prior to first study visit * Patient has been receiving treatment for their DFU for less than 12 weeks. * The chronic DFU is \> 1 cm2 in area and less than 15 cm in length (max. diameter) * 18 years or older * Willing and able to make all required study visits Exclusion Criteria: * • Patients categorized as having a maintenance wound * Use of skin substitutes or hyperbaric oxygen therapy or surgical intervention * Treatment with an investigational drug within 1 month of enrolment * Presents with chronic (\>10 mg/kg for \>30 days) systemic corticoids before enrolment * Has ABI \<0.5 (measured within 3 months of randomisation) * Undergoing chemotherapy or is immunocompromised * Diagnosed with Charcot disease or ulcers from electrical, chemical or radiation burns, or presents with collagen vascular disease, ulcer malignancy, untreated osteomyelitis or cellulitis * Recombinant or autologous growth factors or skin/dermal substitutes within 30 days of enrollment * Inability or unwillingness to consent